Biogen Technology definition

Biogen Technology means the Biogen Program Technology, Jointly-Owned Program Technology, Biogen Product-Specific Patents and any trademarks described in Section 4.1.6, owned, used, developed by, or licensed to Biogen or its Affiliates that is necessary or useful to Develop, register, Manufacture or Commercialize a Product.

Biogen Technology means Biogen Know-How and Biogen Patent Rights.

Biogen Technology means all Technology, exclusive of the Biogen Gene Therapy Technology and the Collaboration Technology, which Biogen owns or otherwise has the right to grant licenses under as of the Original Effective Date or during the term of the Collaboration, which is reasonably necessary to either or both Parties in order to discover, research, develop, make, use, sell or seek approval to market a therapeutic product that comprises a Hedgehog-based Molecular Entity.

Examples of Biogen Technology in a sentence

• All rights in and to Biogen Technology not expressly licensed or assigned to Ionis under this Agreement, are hereby retained by Biogen or its Affiliates.

• In addition, each Party shall provide to the JDC at least ten (10) days in advance of each JDC meeting, summaries of Program Data from such Collaboration Program and any AGTC Technology (including AGTC Improved Technology) or Biogen Technology (including Biogen Platform Improvement Technology), as applicable, arising under such Collaboration Program.

• If TMC terminates this Agreement under Section 10.3 or if Biogen terminates this Agreement under Section 10.2, TMC shall, at TMC's expense, return to Biogen all Biogen Technology furnished to TMC by Biogen, including any unused Biogen Inventory and UCB Material, and shall transfer to Biogen all TMC Technology generated in connection with the Product development and commercialization program.

• Biogen hereby grants to TMC, and TMC hereby accepts from Biogen, a royalty-bearing right and license under Biogen Technology and Biogen Patent Rights to make, have made, import, use, offer to sell and sell Product in the Territory in the Field.

• Further, each Party shall make appropriate personnel available to the other Party at reasonable times and places, including by telephone during normal business hours, and upon reasonable prior notice for the purpose of assisting such other Party to understand and use the applicable AGTC Technology or Biogen Technology for the Development, Manufacture, Commercialization and use of Licensed Products in accordance with this Agreement.

More Definitions of Biogen Technology

Biogen Technology means all Technology which Biogen owns or Controls as of the Effective Date and which is reasonably useful in order to research, develop, make, use, sell or seek approval to market Product.

Biogen Technology means information and materials in the FIELD, including but not limited to, biological materials, technical and non-technical data and information relating to the results of tests, assays, methods, and processes, and drawings, plans, diagrams and specifications and/or other documents containing such information and data owned by BIOGEN or to which BIOGEN has a transferable interest on the EFFECTIVE DATE or prior to termination of this Agreement and which are necessary or useful for the manufacture, use or sale of PRODUCTS.

Biogen Technology means any and all technology, know-how and ----------------- rights owned or Controlled by Biogen or any of its Affiliates during the Development Period with respect to a specific Development Project contemplated under this Agreement to the extent the same directly relate to, are desirable for, or are necessary or useful for, the production, storage and/or marketing of one or more Products and are used or contemplated to be used in connection with Targeted's Development Tasks as specified in the Project Plan and Budget applicable to such Development Project.

Biogen Technology means all Intellectual Property, whether patentable or not (i) which Biogen owns or controls as of the Effective Date or as to which Biogen acquires ownership or control at any time during the term of this Agreement, related to DNA sequences encoding Hepatitis B viral antigens, and (ii) which is necessary or useful in order to discover, research, develop, make, use, offer for sale, import, sell or seek approval to market Licensed Products.

Biogen Technology means (a) any Know-How Controlled by Biogen or any of its Affiliates that is (i) necessary for Catalyst to conduct Catalyst Research Activities under the Work Plan, and (ii) actually provided by Biogen to Catalyst for use in such Catalyst Research Activities, and (b) any Patent Rights Controlled by Biogen or any of its Affiliates that Cover or claim such Know-How described in the foregoing clause (a).

Biogen Technology means Biogen [*] Know-How and Biogen [*] Patent Rights. 2 [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Biogen Technology means, with respect to [*], (a) all Know-How [*] Biogen or any of its Affiliates [*] with respect to [*] that (i) [*] Biogen or any of its Affiliates [*] (ii) [*] Biogen or its Affiliates and (iii) [*] under this Agreement and (b) all Patent Rights Controlled by Biogen or any of its Affiliates that Cover or otherwise claim such Know-How. 1.26 “Biogen [*] Technology” means, with respect to [*], (a) all Know-How (i) [*] Biogen’s or its Affiliates’, [*], either [*] or [*], in each case, in connection with [*] with respect to [*] or (ii) [*] Biogen or its Affiliates [*] with respect to [*] that [*] with respect to [*] and (b) all Patent Rights Controlled by Biogen or its Affiliates that Cover or otherwise claim such Know- How described in the foregoing clause (a), but expressly excluding all Biogen [*] Technology. 1.27 “Biosimilar Product” means, with respect to a particular Product in a particular country in the Territory, any biological product sold by a Third Party that is not a Sublicensee of, or Third Party Distributor for, Biogen or its Affiliates and that did not purchase such product in a chain of distribution that included Biogen or any of its Affiliates or Sublicensees, (a) where such product is approved by the applicable Regulatory Authority as biosimilar to or interchangeable with such Product (including, with respect to the United States, a product that is the subject of an application submitted under Section 351(k) of the Public Health Services Act citing the Product as the reference product) or (b) for which the Regulatory Approval otherwise relies on such Product as a reference product or any corresponding foreign application in the Territory (including, with respect to the EU, a marketing authorization application for a biosimilar biological medicinal product pursuant to Article 10(4) of Directive 2001/83/EC). 3 [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.